Trillium Therapeutics ULC
Records under this name other than patents Trillium Therapeutics ULC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Trillium Therapeutics ULC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,969,789 | Treatment of CD47+ Disease Cells with SIRP Alpha-FC Fusions Formerly held In force · High confidence | In force | High confidence | |
| US 10,906,954 | Treatment of CD47+ Disease Cells with SIRP Alpha-FC Fusions Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,446,315 | Enhancement of CD47 Blockade Therapy by Proteasome Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 11,779,631 | Improvements in CD47 Blockade Therapy by Hdac Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 11,771,764 | CD47 Blockade with Radiation Therapy Formerly held In force · High confidence | In force | High confidence | |
| US 12,178,803 | CD47 Blockade with Parp Inhibition for Disease Treatment Formerly held In force · High confidence | In force | High confidence |